Canada can be a leader in delivering widespread, well-regulated psychedelic-assisted therapy for people with depression, anxiety, post-traumatic stress disorder and substance abuse, by investing in research, educating health care professionals and providing the necessary clinical infrastructure, Dr. Ross Marshall, chief scientific officer at The Newly Institute based in Calgary, says in an op-ed.
Topic: psilocybin
The Short Report – Sept. 1, 2021: Liberals release their campaign platform, feedback sought on new CFI fund, industrial R&D on par with 2019, and more
FEDERAL ELECTION The Liberal Party of Canada released its full platform on Wednesday, including a number of promises on research and innovation. The party’s proposals include a permanent Council of Economic Advisors, reforms to the Scientific Research and Experimental Development Program to “reduce red tape,” an additional 1,000 Canada Research Chairs, a $75-million fund to help colleges and…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...